Hyderabad, India

Srikanth Konda

This inventor holds 1 USPTO granted patent. Top assignee: Laurus Labs Private Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srikanth Konda. Retrieved from https://idiyas.com/inventor/srikanth-konda-gmxryssz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Srikanth Konda: Innovator in Pharmaceutical Processes

Introduction

Srikanth Konda is a notable inventor based in Hyderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Tezacaftor. His work is characterized by a focus on innovative processes that enhance the efficacy of pharmaceutical compositions.

Latest Patents

Konda holds a patent for "Processes for preparation of Tezacaftor." This invention relates to the methods for preparing Tezacaftor and includes pharmaceutical compositions that comprise this compound. The patent also covers novel intermediates of Tezacaftor, detailing processes for their preparation and their use in the synthesis of Tezacaftor.

Career Highlights

Currently, Srikanth Konda is associated with Laurus Labs Private Limited, a prominent player in the pharmaceutical industry. His role at Laurus Labs has allowed him to apply his expertise in drug development and process optimization. Konda's innovative approach has contributed to the advancement of pharmaceutical technologies.

Collaborations

Some of his notable coworkers include Ravindra Babu Bollu and Venkateswar Rao Challagonda. Their collaboration has fostered a productive environment for research and development within the company.

Conclusion

In summary, Srikanth Konda is a distinguished inventor whose work in the preparation of Tezacaftor has made a significant impact in the pharmaceutical field. His contributions continue to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…